Acadia Pharmaceuticals reported $-33651000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Aptinyx Inc APTX:US $ -17105000 2.27M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bristol Myers Squibb BMY:US $ 2590M 37M
Cara Therapeutics CARA:US $ -4472000 23.44M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Cytokinetics CYTK:US $ -10.87M 69.68M
Eisai 4523:JP Y 7434M 28237M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
Johnson & Johnson JNJ:US $ 5840M 22M
Marinus Pharmaceuticals MRNS:US $ -36.77M 20.06M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Pfizer PFE:US $ 12102M 2229M
Prothena PRTA:US -43209000 5.26M
Ptc Therapeutics PTCT:US $ -92.36M 5.84M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vanda Pharmaceuticals VNDA:US $ 3.46M 11.13M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
YTE INCY:US $ 254.43M 137.89M